Derek Hicks - 04 Jan 2023 Form 4 Insider Report for Intellia Therapeutics, Inc. (NTLA)

Signature
James Basta, attorney-in-fact
Issuer symbol
NTLA
Transactions as of
04 Jan 2023
Net transactions value
-$67,425
Form type
4
Filing time
06 Jan 2023, 16:29:43 UTC
Previous filing
05 Jan 2022
Next filing
03 Mar 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NTLA Common Stock Sale $67,425 -1,812 -9.5% $37.21 17,306 04 Jan 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares sold in sell-to-cover transaction in order to satisfy withholding taxes to be paid upon the vesting of RSUs on January 3, 2023.